ArticleCureus2026
Improving Recognition and Reporting of Malignant Central Airways Obstruction on CT: The Need for Standardized Terminology and Structured Reporting.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Malignant central airways obstruction (CAO) is a clinically significant complication of lung cancer that can lead to severe morbidity if not promptly recognized and is frequently under-reported on CT. Methodology All new annual lung cancer baseline CT scans were retrospectively reviewed as part of an audit process in 2014, 2019, and 2020. CT scans were assessed by the interventional pulmonology team. Patients with radiological CAO, defined as obstruction >50% in the trachea, main bronchi, or bronchus intermedius, were assessed. Narrative reports were separated into the main text section, conclusion, and addendum sections. Key phrases describing CAO were then extracted for further analysis. Analysis was performed in R Studio, tidytext, and wordcloud packages. Results In total, 140/1,096 (13%) new diagnoses of lung cancer had severe CAO on admission. No difference was seen across the three time periods (45/342 (13%) in 2014, 43/370 (12%) in 2019, and 52/351 (15%) in 2020;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.